BPCE SA:企業のM&A・事業提携・投資動向

◆英語タイトル:BPCE SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1224
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:61
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

BPCE SA – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s BPCE SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by BPCE SA since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes BPCE SA’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by BPCE SA. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on BPCE SA’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by BPCE SA and its subsidiaries since 2007.
- Information about key financial and legal advisors for BPCE SA’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about BPCE SA’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
PARTNERSHIP 13
Partnership – Overview 13
Partnership – Deal reports 14
CAPITAL RAISING 18
Capital Raising – Overview 18
Capital Raising – Deal reports 19
DIVESTMENTS 27
Divestments – Overview 27
Divestments – Deal reports 28
APPENDIX 51
Contact Us 51
About MarketLine Financial Deals Database 51
Deal Definition and Methodology 53
About MarketLine 60

List of Tables
Table 1: Groupe BPCE M&A volume and value trend (2014-YTD2018)
Table 2: Groupe BPCE M&A activity by geography (2014-YTD2018)
Table 3: Groupe BPCE partnership volume and value trend (2014-YTD2018)
Table 4: Groupe BPCE partnership trend by key deal type (2014-YTD2018)
Table 5: Groupe BPCE capital raising volume and value trend (2014-YTD2018)
Table 6: Groupe BPCE capital raising by deal type (2014-YTD2018)
Table 7: Groupe BPCE divestments volume and value trend (2014-YTD2018)
Table 8: Groupe BPCE divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Groupe BPCE M&A volume and value trend (2014-YTD2018)
Figure 2: Groupe BPCE M&A activity by geography (2014-YTD2018)
Figure 3: Groupe BPCE partnership volume and value trend (2014-YTD2018)
Figure 4: Groupe BPCE partnership trend by key deal type (2014-YTD2018)
Figure 5: Groupe BPCE capital raising volume and value trend (2014-YTD2018)
Figure 6: Groupe BPCE capital raising by deal type (2014-YTD2018)
Figure 7: Groupe BPCE divestments volume and value trend (2014-YTD2018)
Figure 8: Groupe BPCE divestments by geography (2014-YTD2018)

★海外企業調査レポート[BPCE SA:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Avangrid Renewables LLC:電力:M&Aディール及び事業提携情報
    Summary Avangrid Renewables LLC (Avangrid Renewables) a subsidiary of Avangrid Renewables Holdings, Inc., is a renewable energy company that carries out electricity generation from renewable energy sources including wind, biomass, solar energy and thermal energy. The company also provides services s …
  • Domtar Corp (UFS):企業の財務・戦略的SWOT分析
    Domtar Corp (UFS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Intralot S.A. (INLOT):企業の財務・戦略的SWOT分析
    Intralot S.A. (INLOT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Lansforsakringar AB:企業の戦略・SWOT・財務分析
    Lansforsakringar AB - Strategy, SWOT and Corporate Finance Report Summary Lansforsakringar AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Laboratorios Liomont SA de CV:製薬・医療:M&Aディール及び事業提携情報
    Summary Laboratorios Liomont SA de CV (Liomont) is a pharmaceutical company that develops medication products. The company offers prescription medication products, biotech products and over the counter products. It provides drugs in various therapeutic areas including analgesics, antiparasitic, anti …
  • Habib Metropolitan Bank Limited:企業の戦略・SWOT・財務分析
    Habib Metropolitan Bank Limited - Strategy, SWOT and Corporate Finance Report Summary Habib Metropolitan Bank Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Jounce Therapeutics Inc (JNCE):製薬・医療:M&Aディール及び事業提携情報
    Summary Jounce Therapeutics Inc (Jounce) is a clinical stage immunotherapy company that develops therapies that enable the immune system to attack tumors. The company provides JTX-2011, an anti-ICOS monoclonal antibody which stimulates T effector cells to enhance anti-tumor activity; JTX-4014, an an …
  • Sebia SA:企業の製品パイプライン分析2018
    Summary Sebia SA (Sebia) is a medical device company that designs, manufactures, commercializes, and exports electrophoresis tests and analyzers. The company's electrophoresis program offers automated system for capillary electrophoresis, gel electrophoresis and electrophoresis scanning software. It …
  • Dimerix Bioscience Pty Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Dimerix Bioscience Pty Ltd (Dimerix), a subsidiary of Sun Biomedical Ltd is a biopharmaceutical company that offers drug discovery assays and progressing clinical programs. The company provides product development, discovery services, and others. It provides Receptor-HIT a cell-based assay a …
  • APA Group:企業のM&A・事業提携・投資動向
    APA Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's APA Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • The Greenbrier Companies Inc:企業の戦略・SWOT・財務情報
    The Greenbrier Companies Inc - Strategy, SWOT and Corporate Finance Report Summary The Greenbrier Companies Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Enzo Biochem Inc (ENZ):企業の財務・戦略的SWOT分析
    Enzo Biochem Inc (ENZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Kaiser Permanente:企業の戦略・SWOT・財務情報
    Kaiser Permanente - Strategy, SWOT and Corporate Finance Report Summary Kaiser Permanente - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Linamar Corporation (LNR):企業の財務・戦略的SWOT分析
    Linamar Corporation (LNR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Almac Discovery Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Almac Discovery Ltd (Almac Discovery), a subsidiary of Almac Group Ltd is a healthcare service provider that discovers and develops drugs for the treatment of cancer. The company develops drugs, small molecule and therapeutic peptide, biomarkers and diagnostic tools. It provides early drug d …
  • Critical Outcome Technologies Inc (COT)-製薬・医療分野:企業M&A・提携分析
    Summary Critical Outcome Technologies Inc (COTI) is a biopharmaceutical company that develops targeted therapeutics with focus on oncology. The company’s lead program COTI-2 is a novel small molecule activator of misfolded mutant p53 proteins for the treatment of ovarian and other gynecological canc …
  • Polpharma SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Polpharma SA (Polpharma) undertakes the research, manufacture and marketing of generic drugs, prescription drugs and over the counter medications. It provides drugs in cardiology, gastroenterology and neurology areas. The company also manufactures over the counter (OTC) medications, dietary …
  • DexTech Medical AB:製薬・医療:M&Aディール及び事業提携情報
    Summary DexTech Medical AB (DexTech) is a research company that conducts research in the areas of urological oncology, mainly within prostate cancer. The company develops product candidates based on a modified carbon hydrate molecule combined with active substances such as generics. Its technology p …
  • Cleco Corporate Holdings LLC:企業の戦略的SWOT分析
    Cleco Corporate Holdings LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • AnaptysBio Inc:企業のM&A・事業提携・投資動向
    AnaptysBio Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's AnaptysBio Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆